Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-29

Clinical Trial Update: Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the safety and immunogenicity of Purified Verocell Rabies Vaccine (PVRV) administered intramuscularly and intradermally.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified Verocell Rabies Vaccine PVRV (purified vero cell rabies vaccine)

Snippet

Sponsor: University of Peshawar | Conditions: Rabies | Phase 4 | Status: COMPLETED